Klotho Neurosciences Stock Net Income
| KLTO Stock | 0.32 0.01 3.03% |
As of the 26th of January, Klotho Neurosciences secures the Risk Adjusted Performance of (0.07), standard deviation of 5.97, and Mean Deviation of 4.55. Klotho Neurosciences technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
Klotho Neurosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Klotho Neurosciences' valuation are provided below:Klotho Neurosciences does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Klotho Neurosciences. If investors know Klotho will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Klotho Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Klotho Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Klotho Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klotho Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Klotho Neurosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Klotho Neurosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Klotho Neurosciences.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Klotho Neurosciences on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Klotho Neurosciences or generate 0.0% return on investment in Klotho Neurosciences over 90 days. Klotho Neurosciences is related to or competes with Cadrenal Therapeutics, Rallybio Corp, Exicure, Minerva Neurosciences, IBio Common, Neurosense Therapeutics, and TAO Synergies. More
Klotho Neurosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Klotho Neurosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Klotho Neurosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 28.13 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 10.34 |
Klotho Neurosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Klotho Neurosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Klotho Neurosciences' standard deviation. In reality, there are many statistical measures that can use Klotho Neurosciences historical prices to predict the future Klotho Neurosciences' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | 4.03 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Klotho Neurosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Klotho Neurosciences January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 4.04 | |||
| Mean Deviation | 4.55 | |||
| Coefficient Of Variation | (935.17) | |||
| Standard Deviation | 5.97 | |||
| Variance | 35.62 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | 4.03 | |||
| Maximum Drawdown | 28.13 | |||
| Value At Risk | (8.57) | |||
| Potential Upside | 10.34 | |||
| Skewness | 0.7191 | |||
| Kurtosis | 0.7092 |
Klotho Neurosciences Backtested Returns
Klotho Neurosciences has Sharpe Ratio of -0.11, which conveys that the firm had a -0.11 % return per unit of risk over the last 3 months. Klotho Neurosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Klotho Neurosciences' Risk Adjusted Performance of (0.07), mean deviation of 4.55, and Standard Deviation of 5.97 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.16, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Klotho Neurosciences are expected to decrease at a much lower rate. During the bear market, Klotho Neurosciences is likely to outperform the market. At this point, Klotho Neurosciences has a negative expected return of -0.64%. Please make sure to verify Klotho Neurosciences' total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Klotho Neurosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.38 |
Below average predictability
Klotho Neurosciences has below average predictability. Overlapping area represents the amount of predictability between Klotho Neurosciences time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Klotho Neurosciences price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Klotho Neurosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.38 | |
| Spearman Rank Test | 0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Klotho Neurosciences reported net income of (6.15 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is notably higher than that of the company.
Klotho Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klotho Neurosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klotho Neurosciences could also be used in its relative valuation, which is a method of valuing Klotho Neurosciences by comparing valuation metrics of similar companies.Klotho Neurosciences is currently under evaluation in net income category among its peers.
Klotho Fundamentals
| Return On Equity | -1.98 | ||||
| Return On Asset | -0.72 | ||||
| Current Valuation | 24.87 M | ||||
| Shares Outstanding | 72.54 M | ||||
| Shares Owned By Insiders | 21.23 % | ||||
| Shares Owned By Institutions | 2.60 % | ||||
| Number Of Shares Shorted | 482.73 K | ||||
| Price To Book | 2.38 X | ||||
| EBITDA | (5.79 M) | ||||
| Net Income | (6.15 M) | ||||
| Total Debt | 271.75 K | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (2.95 M) | ||||
| Short Ratio | 0.61 X | ||||
| Earnings Per Share | (0.30) X | ||||
| Beta | 2.48 | ||||
| Market Capitalization | 23.67 M | ||||
| Total Asset | 2.46 M | ||||
| Retained Earnings | (10.56 M) | ||||
| Working Capital | (1.09 M) | ||||
| Net Asset | 2.46 M |
About Klotho Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Klotho Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klotho Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Klotho Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Klotho Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Klotho Stock
Moving against Klotho Stock
| 0.85 | FBIO | Fortress Biotech | PairCorr |
| 0.8 | DRTS | Alpha Tau Medical | PairCorr |
| 0.72 | IPSC | Century Therapeutics Buyout Trend | PairCorr |
| 0.62 | CADL | Candel Therapeutics | PairCorr |
| 0.49 | DMAC | DiaMedica Therapeutics | PairCorr |
The ability to find closely correlated positions to Klotho Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences to buy it.
The correlation of Klotho Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Klotho Neurosciences Piotroski F Score and Klotho Neurosciences Altman Z Score analysis. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Klotho Neurosciences. If investors know Klotho will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Klotho Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Klotho Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Klotho Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Klotho Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.